Get Premium to unlock powerful stock data
NAS:IPSC (USA)  
Century Therapeutics Inc logo

Century Therapeutics Inc

$ 9.15 +0.36 (+4.1%) 10:08 PM EST
P/E:
At Loss
P/B:
1.36
Market Cap:
$ 538.48M
Enterprise V:
$ 181.31M
Volume:
101.52K
Avg Vol (2M):
113.95K
Volume:
101.52K
Market Cap $:
538.48M
PE Ratio:
At Loss
Avg Vol (2-Month):
113.95K
Enterprise Value $:
181.31M
PB Ratio:
1.36
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Century Therapeutics Inc
NAICS : 541714 SIC : 2833
3675 Market Street, Philadelphia, PA, USA, 19104
Description
Century Therapeutics Inc is a biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with a significant unmet medical need. It is assembling a portfolio of allogeneic iNK and iT cell therapy product candidates across solid tumor and hematological malignancies.
Name Current Vs Industry Vs History
Cash-To-Debt 14.42
Equity-to-Asset 0.7
Debt-to-Equity 0.07
Debt-to-EBITDA -0.23
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.88
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 65.73
9-Day RSI 57.85
14-Day RSI 53.55
6-1 Month Momentum % -43.66
12-1 Month Momentum % -72.52

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 16.62
Quick Ratio 16.62
Cash Ratio 16.43

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2022-08-12 Est.)

IPSC's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:IPSC

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.058
EPS (TTM) ($) -3.583
Beta 0
Volatility % 34.55
14-Day RSI 53.55
14-Day ATR ($) 0.886737
20-Day SMA ($) 8.6315
12-1 Month Momentum % -72.52
52-Week Range ($) 7.32 - 32.899
Shares Outstanding (Mil) 58.85

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Century Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More